YourRad AB is Providing MVision’s AI-Powered Segmentation Service to Nordic Cancer Hospitals

Helsinki – 5th of November, 2021 – MVision AI, the pioneer of SaaS radiotherapy treatment planning optimization, announces their distribution partnership YourRad AB, the prime supplier of radiation treatment products for Nordic Clinics.

The commitment authorizes YourRad AB with the entitlement to distribute products and services of MVision AI in the Nordic region. YourRad AB and MVision AI are devoted to accelerated, prime, and guideline-based provisions of radiotherapy solutions for Nordic radiation oncology practices. The MVision AI team will collaborate with YourRad staff to assure the dispensation of superior, swift, and dependable radiotherapy services.

“We are happy and proud of the partnership with MVISION Oy. The feedback from our end users in radiotherapy have been excellent. It mainly highlights the fact that the quality and consistency are excellent and that the value for both health care professionals and patients is great. Very high quality in delineating OAR´s and time saving are the key benefits according to customers,” says M. Forss, CEO of YourRad AB. 

As stated by Mahmudul Hasan, CEO, and co-founder of MVision AI, “MVision is delighted to partner with YourRad AB to bring our guideline-based AI segmentation (GBAIS™ and GCAIS™) to Nordic customers. Nordic countries have always been at the forefront of adopting cutting-edge technologies. MVision is excited to bring more innovative solutions to facilitate same-day treatment as a reality.”

For additional information on YourRad AB:

Magasinsgatan 8C, 434 37, Kungsbacka, Sweden

Tel: +46 (0) 70 609 88 91 

Email: info@yourrad.se

LinkedIn: https://www.linkedin.com/company/yourrad-ab/?originalSubdomain=se 

For supplementary information on MVision AI: 

c/o Terkko Health Hub, Haartmaninkatu 4, 00290 Helsinki, Finland.

Tel: +358 (0) 40 5489 229

Website: https://www.mvision.ai 

Email: info@mvision.ai 

Social Media: Facebook, Instagram, LinkedIn, Twitter, and Youtube

For media inquiries:

Tel: +358 40 500 7915

Email: pr@mvision.ai

 

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

13.12.2024

Saad Ullah Akram Appointed as CEO of MVision AI

Helsinki, Finland – MVision AI, a leading provider of AI-powered solutions for radiation therapy treatment planning, announces the appointment of Saad Ullah Akram as its new Chief Executive Officer. Known for its commitment to streamlining workflows and enhancing treatment quality in cancer care, MVision AI is embarking on an exciting…

Press Releases

20.11.2024

MVision AI Ranked Among the Top 10 in Deloitte Technology Fast 50 Finland for 2024

Helsinki, Finland, 20 November 2024 – MVision AI, a leading innovator in AI-driven solutions for oncology, is proud to announce its recognition among the top ten companies in the Deloitte Technology Fast 50 Finland 2024 ranking. This prestigious award acknowledges MVision AI's rapid growth and its mission-driven advancements in making…

Press Releases

7.11.2024

Safe and Ethical AI in Radiation Oncology: Regulations and MVision’s Compliance

Technology is evolving, and the same applies to Radiation Oncology. New ways and new tools require new rules. Artificial intelligence (AI)  brings tremendous potential, so the world has to learn how to get the best of it, safely.  Al systems identified as high-risk have to comply with strict requirements, including…

Articles